Elevation Oncology Inc
NASDAQ:ELEV
Elevation Oncology Inc
NASDAQ:ELEV
Price:
3.83 USD
-0.26%
Market Closed
Updated:
May 29, 2024
Elevation Oncology Inc
Net Issuance of Debt
|
Elevation Oncology Inc
Net Issuance of Debt Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Elevation Oncology Inc
NASDAQ:ELEV
|
Net Issuance of Debt
$46.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Debt
$12.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
181%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Debt
$2.6B
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Debt
-$45.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
4%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Elevation Oncology Inc's Net Issuance of Debt?
Net Issuance of Debt
46.5m
USD
46.5m
USD
Based on the financial report for Dec 31, 2023, Elevation Oncology Inc's Net Issuance of Debt amounts to 46.5m USD.
What is Elevation Oncology Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 1Y
55%
55%
Over the last year, the Net Issuance of Debt growth was 55%.
You don't have any saved screeners yet
